Florian Brand - 29 Mar 2023 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role
Co-Founder & Chief Executive Officer
Signature
/s/ Ryan Barrett, Attorney-in-fact
Issuer symbol
ATAI
Transactions as of
29 Mar 2023
Net transactions value
+$103,558
Form type
4
Filing time
30 Mar 2023, 17:55:18 UTC
Previous filing
16 Mar 2023
Next filing
14 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATAI Common Shares Purchase $103,558 +70,000 $1.48 70,000 29 Mar 2023 Direct F1
holding ATAI Common Shares 2,333 29 Mar 2023 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $1.40 to $1.55. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.

Remarks:

Co-Founder & Chief Executive Officer